These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
620 related articles for article (PubMed ID: 28030783)
41. Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer. Shigematsu H; Ozaki S; Yasui D; Zaitsu J; Taniyama D; Saitou A; Kuraoka K; Yamashiro H; Taniyama K Breast Cancer; 2018 Mar; 25(2):191-197. PubMed ID: 29094254 [TBL] [Abstract][Full Text] [Related]
42. Using one-step nucleic acid amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients avoids second surgery and accelerates initiation of adjuvant therapy. Klingler S; Marchal F; Rauch P; Kenouchi O; Chrétien AS; Genin P; Leroux A; Merlin JL Ann Oncol; 2013 Sep; 24(9):2305-9. PubMed ID: 23661291 [TBL] [Abstract][Full Text] [Related]
43. Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay. Fung V; Kohlhardt S; Vergani P; Zardin GJ; Williams NR Mol Clin Oncol; 2017 Nov; 7(5):755-762. PubMed ID: 29142748 [TBL] [Abstract][Full Text] [Related]
44. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes. Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789 [TBL] [Abstract][Full Text] [Related]
45. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Visser M; Jiwa M; Horstman A; Brink AA; Pol RP; van Diest P; Snijders PJ; Meijer CJ Int J Cancer; 2008 Jun; 122(11):2562-7. PubMed ID: 18324628 [TBL] [Abstract][Full Text] [Related]
46. [A nomogram to predict non-sentinel lymph node metastasis for breast cancer patients with positive axillary sentinel lymph node]. Yang ZB; Huang Z; Wang SL; Tang Y; Jing H; Wang JY; Zhang JH; Yang Y; Song YW; Fang H; Jin J; Liu YP; Qi SN; Li N; Tang Y; Lu NN; Chen B; Wang X; Gao JD; Wang J; Xuan LX; Fang Y; Li YX Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):653-659. PubMed ID: 32867457 [No Abstract] [Full Text] [Related]
47. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE; Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163 [TBL] [Abstract][Full Text] [Related]
48. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010 [TBL] [Abstract][Full Text] [Related]
49. Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study. Vegué LB; Rojo F; Hardisson D; Iturriagagoitia AC; Panadés MJ; Velasco A; Bonet EL; Muñoz RC; Polo L; Diagn Mol Pathol; 2012 Jun; 21(2):69-76. PubMed ID: 22555089 [TBL] [Abstract][Full Text] [Related]
50. [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node]. Huang J; Chen X; Fei X; Huang O; Wu J; Zong Y; Zhu L; He J; Chen W; Li Y; Shen K Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):941-6. PubMed ID: 26850667 [TBL] [Abstract][Full Text] [Related]
51. Performance of a new system using a one-step nucleic acid amplification assay for detecting lymph node metastases in breast cancer. Shimazu K; Tanei T; Tamaki Y; Saeki T; Osaki A; Hasebe T; Tomita Y; Daito M; Kobayashi M; Noguchi S Med Oncol; 2019 May; 36(6):54. PubMed ID: 31062258 [TBL] [Abstract][Full Text] [Related]
52. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
53. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay. Bernet-Vegué L; Cantero-González C; Sancho de Salas M; Parada D; Perin T; Quintero-Niño Z; Vieites Pérez-Quintela B; Sánchez-Guzmán D; Castelvetere M; Hardisson Hernaez D; Martín-Salvago MD Clin Transl Oncol; 2024 May; 26(5):1220-1228. PubMed ID: 38070048 [TBL] [Abstract][Full Text] [Related]
54. Is OSNA better than imprint cytology for intraoperative diagnosis of cancer involvement of axillary sentinel node in breast cancer? Luna-Tomás MA; Solà-Suárez M; Mariscal-Martínez A; Castellà-Fernández E; Martínez-Román S; Pascual-Miguel I; Quiroga-García V; Julián-Ibáñez JF Breast; 2018 Apr; 38():181-187. PubMed ID: 29455041 [TBL] [Abstract][Full Text] [Related]
55. A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients. Terrenato I; D'Alicandro V; Casini B; Perracchio L; Rollo F; De Salvo L; Di Filippo S; Di Filippo F; Pescarmona E; Maugeri-Saccà M; Mottolese M; Buglioni S PLoS One; 2017; 12(2):e0171517. PubMed ID: 28187209 [TBL] [Abstract][Full Text] [Related]
56. Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison. Fanfani F; Monterossi G; Di Meo ML; La Fera E; Dell'Orto F; Gioè A; Lamanna M; Ferrari D; De Ponti E; Perego P; Restaino S; Carlo R; Zannoni GF; Landoni F; Scambia G; Buda A Int J Gynecol Cancer; 2020 Mar; 30(3):372-377. PubMed ID: 31996396 [TBL] [Abstract][Full Text] [Related]
57. Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients. Le Frère-Belda MA; Bats AS; Gillaizeau F; Poulet B; Clough KB; Nos C; Peoc'h M; Seffert P; Bouteille C; Leroux A; Guillemin F; Blanc-Fournier C; Crouet H; Arnould L; Cuisenier J; Penault-Llorca F; Gimbergues P; Jacquemier J; Houvenaeghel G; Chatellier G; Lécuru F Int J Cancer; 2012 May; 130(10):2377-86. PubMed ID: 21780107 [TBL] [Abstract][Full Text] [Related]
58. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients. van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438 [TBL] [Abstract][Full Text] [Related]
59. Implementation of molecular intra-operative assessment of sentinel lymph node in breast cancer. Khaddage A; Berremila SA; Forest F; Clemenson A; Bouteille C; Seffert P; Peoc'h M Anticancer Res; 2011 Feb; 31(2):585-90. PubMed ID: 21378342 [TBL] [Abstract][Full Text] [Related]
60. CK19 mRNA in blood can predict non-sentinel lymph node metastasis in breast cancer. Yu XF; Yang HJ; Lei L; Wang C; Huang J Oncotarget; 2016 May; 7(21):30504-10. PubMed ID: 27105542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]